FDA NDC Directory · JSON-LD · Markdown

Lansoprazole

NDC 55154-4848 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE

Labeler / ManufacturerCardinal Health 107, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA208784
Dosage form / routeTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE · ORAL
Active ingredientsLANSOPRAZOLE (30 mg/1)
Marketing started20180308
Package count1

External sources

Source: openFDA. Public-domain (CC0).